Skip to main content

Cogent Biosciences, Inc.

COGT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001622229

In the last 90 days, Cogent Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 322 institutions reported holding it in 13F filings for Q2 2026, worth $7.50B in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Cogent Biosciences, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of COGT: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders69690
Shares34.5M36.4M+1.92M (+5.6%)
Value$303.3M$293.7M−$9.54M (−3.1%)

New holders (19)

Institutions that held Cogent Biosciences, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to COGT in Q2 2021
InstitutionSharesValue% of portfolio
Nuveen Asset Management, LLC129,850$1.05M0.00%
Charles Schwab Investment Management Inc93,951$762.0K0.00%
California State Teachers Retirement System51,309$416.0K0.00%
Rhumbline Advisers38,280$310.0K0.00%
New York State Common Retirement Fund31,800$258.0K0.00%
Jane Street Group, LLC24,192$196.0K0.00%
Manufacturers Life Insurance Company, The23,235$188.0K0.00%
Deutsche Bank AG22,060$179.0K0.00%
American International Group, Inc.20,820$169.0K0.00%
Voya Investment Management LLC14,956$121.0K0.00%
STRS Ohio8,600$69.0K0.00%
Tower Research Capital LLC (TRC)8,164$66.0K0.00%
Legal & General Group Plc3,238$26.0K0.00%
Ameritas Investment Partners, Inc.2,913$24.0K0.00%
Royal Bank of Canada2,544$21.0K0.00%
Point72 Hong Kong Ltd1,508$12.0K0.00%
Tarbox Family Office, Inc.278$2.00K0.00%
ClariVest Asset Management LLC106$1.00K0.00%
US Bancorp61$00.00%

Sold out (19)

Institutions that held Cogent Biosciences, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.